Загрузка...
Imaging and Therapy of Pancreatic Cancer with Phosphatidylserine-Targeted Nanovesicles()
Pancreatic cancer remains one of the most intractable cancers, with a dismal prognosis reflected by a 5-year survival of ~ 6%. Since early disease symptoms are undefined and specific biomarkers are lacking, about 80% of patients present with advanced, inoperable tumors that represent a daunting chal...
Сохранить в:
| Опубликовано в: : | Transl Oncol |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Neoplasia Press
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4486738/ https://ncbi.nlm.nih.gov/pubmed/26055177 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2015.03.011 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|